Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Grossman

Showing results (21-30 of 131) with videos related to

Pageof 14
Sort By:
The Lancet. Oncology|April 21, 2023
Craniopharyngiomas and proton beam therapy: worth the expense?Ashley Grossman, Michael Kosmin
Touchreviews in Endocrinology|May 30, 2024
Seliciclib: A New Treatment for Cushing's Disease?Eleni Armeni, Ashley Grossman
Annals of the New York Academy of Sciences|October 17, 2002
The medical management of Cushing's syndromeDamian Morris, Ashley Grossman
Journal of Neuroendocrinology|November 12, 2024
Somatostatin receptor-linked α-particle therapy in neuroendocrine tumoursShaunak Navalkissoor, Ashley Grossman
Endocrine|December 25, 2013
The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomasCatrin Lloyd, Ashley Grossman
Clinical Endocrinology|December 29, 2015
Quality indicators in pituitary surgery: a need for reliable and valid assessments. What should be measured?Michael Powell, Ashley Grossman
European Endocrinology|April 11, 2018
New Developments in the Treatment of Neuroendocrine Tumours - RADIANT-4, NETTER-1 and Telotristat EtiprateEmilia Sbardella, Ashley Grossman
Annals of Saudi Medicine|August 9, 2012
The investigation of Cushing syndrome: essentials in optimizing appropriate diagnosis and managementAgata Juszczak, Ashley Grossman
Touchreviews in Endocrinology|January 25, 2023
A New Medical Therapy for Multiple Endocrine Neoplasia Type 1?Hessa Boharoon, Ashley Grossman
European Journal of Endocrinology|October 7, 2017
MANAGEMENT OF ENDOCRINE DISEASE: Flushing: current conceptsIsabel Huguet, Ashley Grossman
Pageof 14

Showing results (21-30 of 131) with videos related to

Sort By:
Pageof 14
The Lancet. Oncology|April 21, 2023
Craniopharyngiomas and proton beam therapy: worth the expense?Ashley Grossman, Michael Kosmin
Touchreviews in Endocrinology|May 30, 2024
Seliciclib: A New Treatment for Cushing's Disease?Eleni Armeni, Ashley Grossman
Annals of the New York Academy of Sciences|October 17, 2002
The medical management of Cushing's syndromeDamian Morris, Ashley Grossman
Journal of Neuroendocrinology|November 12, 2024
Somatostatin receptor-linked α-particle therapy in neuroendocrine tumoursShaunak Navalkissoor, Ashley Grossman
Endocrine|December 25, 2013
The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomasCatrin Lloyd, Ashley Grossman
Clinical Endocrinology|December 29, 2015
Quality indicators in pituitary surgery: a need for reliable and valid assessments. What should be measured?Michael Powell, Ashley Grossman
European Endocrinology|April 11, 2018
New Developments in the Treatment of Neuroendocrine Tumours - RADIANT-4, NETTER-1 and Telotristat EtiprateEmilia Sbardella, Ashley Grossman
Annals of Saudi Medicine|August 9, 2012
The investigation of Cushing syndrome: essentials in optimizing appropriate diagnosis and managementAgata Juszczak, Ashley Grossman
Touchreviews in Endocrinology|January 25, 2023
A New Medical Therapy for Multiple Endocrine Neoplasia Type 1?Hessa Boharoon, Ashley Grossman
European Journal of Endocrinology|October 7, 2017
MANAGEMENT OF ENDOCRINE DISEASE: Flushing: current conceptsIsabel Huguet, Ashley Grossman
Pageof 14